APA aipamena

Lee, T., Lin, C., Chen, C., Wang, T., Lo, G., Chang, C., & Chao, Y. (2017). Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early–intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial. Medicine (Baltimore).

Chicago Style aipamena

Lee, Teng-Yu, Chen-Chun Lin, Chiung-Yu Chen, Tsang-En Wang, Gin-Ho Lo, Chi-Sen Chang, and Yee Chao. "Combination of Transcatheter Arterial Chemoembolization and Interrupted Dosing Sorafenib Improves Patient Survival in Early–intermediate Stage Hepatocellular Carcinoma: A Post Hoc Analysis of the START Trial." Medicine (Baltimore) 2017.

MLA aipamena

Lee, Teng-Yu, et al. "Combination of Transcatheter Arterial Chemoembolization and Interrupted Dosing Sorafenib Improves Patient Survival in Early–intermediate Stage Hepatocellular Carcinoma: A Post Hoc Analysis of the START Trial." Medicine (Baltimore) 2017.